| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.923 | 19 | 0 | 1992 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.300 | None | 0.880 | 8 | 0 | 1990 | 2020 | ||||||||
|
myelin basic protein | 0.510 | 0.885 | 0.28 |
|
disease | 0.100 | None | 0.939 | 8 | 0 | 1990 | 2020 | ||||||||
|
myelin oligodendrocyte glycoprotein | 0.546 | 0.731 | 0.14 |
|
disease | 0.100 | None | 0.972 | 7 | 0 | 1995 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.400 | None | 0.877 | 7 | 0 | 1994 | 2019 | ||||||||
|
interleukin 7 receptor | 0.487 | 0.769 | 3.8E-07 |
|
disease | 0.500 | None | 0.982 | 7 | 0 | 2003 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.400 | None | 0.912 | 6 | 0 | 1991 | 2019 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.100 | None | 0.860 | 5 | 0 | 1998 | 2020 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.400 | None | 0.970 | 4 | 0 | 1994 | 2020 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.867 | 4 | 0 | 2000 | 2009 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.100 | None | 0.929 | 4 | 0 | 1998 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 0.957 | 4 | 0 | 1996 | 2019 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.100 | None | 0.839 | 4 | 0 | 1997 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.400 | None | 0.922 | 4 | 0 | 1996 | 2019 | ||||||||
|
crystallin alpha B | 0.515 | 0.731 | 2.2E-02 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 1996 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.400 | None | 0.846 | 3 | 0 | 1994 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 0.985 | 3 | 0 | 1994 | 2019 | ||||||||
|
MHC class I polypeptide-related sequence B | 0.576 | 0.731 | 4.1E-05 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2008 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.100 | None | 0.947 | 2 | 0 | 2003 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 0.884 | 2 | 0 | 1991 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.100 | None | 0.975 | 2 | 0 | 1999 | 2019 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2002 | 2009 | ||||||||
|
potassium voltage-gated channel subfamily A member 3 | 0.760 | 0.385 | 0.89 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2007 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.100 | None | 0.885 | 2 | 0 | 2001 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.100 | None | 0.927 | 2 | 0 | 1996 | 2019 |